Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity

v3.22.4
Stockholders' Equity
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Stockholders' Equity

NOTE 10. STOCKHOLDERS’ EQUITY

Common Stock Issuances

During the years ended December 31, 2022 and 2021, the Company issued an aggregate of 1,382,091 and 1,176,984 shares of its common stock, respectively, in connection with the exercise of stock options, issuance of stock awards and vesting of restricted stock units under its stock incentive plans and purchases under its Employee Stock Purchase Plan (the “ESPP”). During the year ended December 31, 2022, the Company withheld 502,005 shares of its common stock for employees taxes.

During the year ended December 31, 2022, the Company issued a total of 116,550 shares of its common stock in connection with its March 2022 acquisition. During the year ended December 31, 2022, the Company issued a total of 352,330 shares of its common stock in connection with the contingent consideration arrangement related to the acquisition of PandoLogic.

During the year ended December 31, 2021, the Company issued a total of 252,218 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,279 and issued an aggregate of 23,050 shares of its common stock upon exercises of warrants to purchase an aggregate of 26,000 shares of its common stock, which were effected on a net exercise basis without cash payment of the exercise price.

During the year ended December 31, 2021, the Company issued an aggregate of 15,828 shares of its common stock for services provided to the Company. The Company valued these stock issuances based on the closing price of its common stock on the issuance date and recorded the expense of $369 in general and administrative expenses in the Company’s consolidated statement of operations and comprehensive loss for the year ended December 31, 2021.

Common Stock Warrants

 

The table below summarizes the warrants outstanding at December 31, 2022:

 

 

 

 

 

 

 

 

Number of

 

 

 

 

 

Exercise

 

 

Shares of

 

Issuance Date

 

Life in Years

 

Price

 

 

Common Stock

 

Various dates in 2017

 

10

 

$

13.61

 

 

 

145,945

 

April 2018

 

5

 

$

11.73

 

 

 

20,000

 

April 2020 Performance Warrant

 

3.7

 

$

3.01

 

 

 

330,667

 

 

 

 

 

 

 

 

 

496,612

 

The table below summarizes the warrants outstanding at December 31, 2021:

 

 

 

 

 

 

 

 

Number of

 

 

 

 

 

Exercise

 

 

Shares of

 

Issuance Date

 

Life in Years

 

Price

 

 

Common Stock

 

Various dates in 2017

 

10

 

$

13.61

 

 

 

145,945

 

April 2018

 

5

 

$

11.73

 

 

 

20,000

 

April 2020 Performance Warrant

 

3.7

 

$

3.01

 

 

 

330,667

 

 

 

 

 

 

 

 

 

496,612